Co-Diagnostics, Inc. Common Stock (CODX) - Total Liabilities

Latest as of December 2025: $4.11 Million USD

Based on the latest financial reports, Co-Diagnostics, Inc. Common Stock (CODX) has total liabilities worth $4.11 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CODX cash flow metrics to assess how effectively this company generates cash.

Co-Diagnostics, Inc. Common Stock - Total Liabilities Trend (2014–2025)

This chart illustrates how Co-Diagnostics, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Check Co-Diagnostics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.

Co-Diagnostics, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of Co-Diagnostics, Inc. Common Stock ranked by their total liabilities.

Company	Country	Total Liabilities
Beauce Gold Fields Inc V:BGF	Canada	CA$762.09K
Cluey Ltd AU:CLU	Australia	AU$6.73 Million
European Opportunities Trust plc LSE:EOT	UK	GBX66.66 Million
Mamba Exploration Ltd AU:M24	Australia	AU$217.59K
Nitro Games Oyj ST:NITRO	Sweden	Skr3.77 Million
Rathdowney Resources Ltd V:RTH	Canada	CA$17.57 Million
Ronin Resources Ltd AU:RON	Australia	AU$121.73K
Vsolar Group Bhd KLSE:0066	Malaysia	RM4.73 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Co-Diagnostics, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Co-Diagnostics, Inc. Common Stock stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.17	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Co-Diagnostics, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Co-Diagnostics, Inc. Common Stock (2014–2025)

The table below shows the annual total liabilities of Co-Diagnostics, Inc. Common Stock from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	$4.11 Million	-57.54%
2024-12-31	$9.69 Million	+4.09%
2023-12-31	$9.31 Million	+8.65%
2022-12-31	$8.57 Million	-66.48%
2021-12-31	$25.56 Million	+462.89%
2020-12-31	$4.54 Million	+849.80%
2019-12-31	$478.07K	-81.70%
2018-12-31	$2.61 Million	+221.75%
2017-12-31	$811.80K	-81.08%
2016-12-31	$4.29 Million	+182.58%
2015-12-31	$1.52 Million	+1152.55%
2014-12-31	$121.22K	--

About Co-Diagnostics, Inc. Common Stock

NASDAQ:CODX USA Medical Devices

Market Cap

$5.58 Million

Market Cap Rank

#28365 Global

#5585 in USA

Share Price

$1.55

Change (1 day)

+0.00%

52-Week Range

$0.17 - $6.19

All Time High

$30.80